Literature DB >> 27552340

Symptoms of Depression, Positive Symptoms of Psychosis, and Suicidal Ideation Among Adults Diagnosed With Schizophrenia Within the Clinical Antipsychotic Trials of Intervention Effectiveness.

Lindsay A Bornheimer, James Jaccard.   

Abstract

Suicide is among leading causes of death for adults diagnosed with schizophrenia. While symptoms of depression are consistently supported factors involved in suicidal ideation, findings on the role of positive symptoms of psychosis have been mixed with limited understandings of risk. Accordingly, this study aimed to identify the pathways of influence between symptoms of depression, positive symptoms of psychosis (i.e. hallucinations and delusions), and suicidal ideation. Data were obtained from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE; n = 1,460). Suicidal ideation and symptoms of depression were measured by the Calgary Depression Scale (CDRS) and hallucinations and delusions by the Positive and Negative Syndrome Scale (PANSS). The data were analyzed using Structural Equation Modeling (SEM). As symptoms of depression and positive symptoms of psychosis independently increased, on average there were associated increases in suicidal ideation. The present study provides support for the relationship between positive symptoms of psychosis, specifically hallucinations and delusions, and suicidal ideation. Future prospective longitudinal study designs are needed to further increase understandings of the roles that hallucinations, delusions, and additional symptoms of schizophrenia play in both suicidal ideation and attempt to ultimately inform evidence-based interventions aiming to reduce suicidal death.

Entities:  

Keywords:  CATIE; depression; psychosis; suicide

Mesh:

Substances:

Year:  2016        PMID: 27552340      PMCID: PMC5784410          DOI: 10.1080/13811118.2016.1224990

Source DB:  PubMed          Journal:  Arch Suicide Res        ISSN: 1381-1118


  36 in total

Review 1.  Suicide and schizophrenia.

Authors:  S G Siris
Journal:  J Psychopharmacol       Date:  2001-06       Impact factor: 4.153

2.  Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries.

Authors:  Antonio Lora; Robert Kohn; Itzhak Levav; Ryan McBain; Jodi Morris; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2011-10-31       Impact factor: 9.408

3.  Four studies on how past and current suicidality relate even when "everything but the kitchen sink" is covaried.

Authors:  Thomas E Joiner; Yeates Conwell; Kathleen Kara Fitzpatrick; Tracy K Witte; Norman B Schmidt; Marcelo T Berlim; Marcelo P A Fleck; M David Rudd
Journal:  J Abnorm Psychol       Date:  2005-05

Review 4.  Schizophrenia and suicide: systematic review of risk factors.

Authors:  Keith Hawton; Lesley Sutton; Camilla Haw; Julia Sinclair; Jonathan J Deeks
Journal:  Br J Psychiatry       Date:  2005-07       Impact factor: 9.319

Review 5.  Suicide and awareness of illness in schizophrenia: an overview.

Authors:  Maurizio Pompili; Amedeo Ruberto; Giorgio D Kotzalidis; Paolo Girardi; Roberto Tatarelli
Journal:  Bull Menninger Clin       Date:  2004

6.  Psychosis and functioning as risk factors for later suicidal activity among schizophrenia and schizoaffective patients: a disease-based interactive model.

Authors:  K J Kaplan; M Harrow
Journal:  Suicide Life Threat Behav       Date:  1999

7.  A depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; B Schissel
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

8.  The omnipotence of voices. A cognitive approach to auditory hallucinations.

Authors:  P Chadwick; M Birchwood
Journal:  Br J Psychiatry       Date:  1994-02       Impact factor: 9.319

9.  Suicide attempts in schizophrenia: the role of command auditory hallucinations for suicide.

Authors:  Jill M Harkavy-Friedman; David Kimhy; Elizabeth A Nelson; David F Venarde; Dolores Malaspina; J John Mann
Journal:  J Clin Psychiatry       Date:  2003-08       Impact factor: 4.384

10.  Predicting compliance with command hallucinations.

Authors:  J Junginger
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

View more
  6 in total

1.  Modifying a cognitive behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health.

Authors:  Lindsay A Bornheimer; Juliann Li Verdugo; Joshua Holzworth; Vitalis Im; Fonda N Smith; Hannah Sliwa; Stephan F Taylor; Cheryl A King; Timothy Florence; Nicholas Tarrier; Joseph A Himle
Journal:  Psychiatry Res       Date:  2022-03-07       Impact factor: 11.225

2.  Self-harm and suicide attempts in Schizophrenia.

Authors:  Kiran Jakhar; Ram Pratap Beniwal; Triptish Bhatia; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2017-08-18

3.  Genome-wide methylation association with current suicidal ideation in schizophrenia.

Authors:  Ali Bani-Fatemi; Christopher Adanty; Nasia Dai; Oluwagbenga Dada; John Strauss; Clement Zai; Philip Gerretsen; Ariel Graff; Vincenzo De Luca
Journal:  J Neural Transm (Vienna)       Date:  2020-07-13       Impact factor: 3.575

4.  Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition.

Authors:  Lindsay A Bornheimer; Jessica A Wojtalik; Juliann Li; Derin Cobia; Matthew J Smith
Journal:  Schizophr Res       Date:  2021-01-23       Impact factor: 4.939

5.  Potential metabolic monitoring indicators of suicide attempts in first episode and drug naive young patients with major depressive disorder: a cross-sectional study.

Authors:  Ke Zhao; Siyao Zhou; Xiang Shi; Jianjun Chen; Yaoyao Zhang; Kaili Fan; Xiangyang Zhang; Wei Wang; Wei Tang
Journal:  BMC Psychiatry       Date:  2020-07-28       Impact factor: 3.630

6.  Psychometric properties of the Suicidal Ideation Attributes Scale (SIDAS) in a longitudinal sample of people experiencing non-affective psychosis.

Authors:  Kamelia Harris; Gillian Haddock; Sarah Peters; Patricia Gooding
Journal:  BMC Psychiatry       Date:  2021-12-16       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.